Ribosomal RNA (rRNA) genes are down-regulated during osteogenesis, myogenesis, and adipogenesis, necessitating a mechanistic understanding of interrelationships between growth control and phenotype commitment. Here, we show that cell fate-determining factors [MyoD, myogenin (Mgn) , Runx2, C/EBP␤] occupy rDNA loci and suppress rRNA expression during lineage progression, concomitant with decreased rRNA expression and reciprocal loss of occupancy by c-Myc, a proliferation-specific activator of rRNA transcription. We find interaction of phenotypic factors with the polymerase I activator upstream binding factor UBF-1 at interphase nucleoli, and this interaction is epigenetically retained on mitotic chromosomes at nucleolar organizing regions. Ectopic expression and RNA interference establish that MyoD, Mgn, Runx2, and C/EBP␤ each functionally suppress rRNA genes and global protein synthesis. We conclude that epigenetic control of ribosomal biogenesis by lineage-specific differentiation factors is a general developmental mechanism for coordinate control of cell growth and phenotype.
R
ibosomal biogenesis is directly linked to cell growth and proliferation (1) . Actively dividing cells require continuous ribosome synthesis to ensure that progeny cells have the capacity to support protein synthesis after cell division. A control point in the complex process of ribosome biogenesis is the transcriptional regulation of ribosomal RNA (rRNA) genes, which are transcribed by the RNA polymerase I (pol I) machinery. Although regulation of ribosomal biogenesis during the cell cycle is well documented (2) , mechanisms that interrelate control of protein synthesis and lineage commitment are minimally understood.
Mesenchymal progenitor cells have the capacity to differentiate into cell lineages that include adipocytes, myoblasts, and osteoblasts (3) . Phenotype determination requires integration of extracellular physiological cues and temporal up-regulation of cell type-specific regulatory proteins. During differentiation, cells undergo a phase of rapid proliferation and then withdraw from the cell cycle, concomitant with the expression of lineage-specific transcription factors. For example, osteoblast differentiation of mesenchymal progenitors requires induction of Runx2 (4, 5) , whereas adipogenesis is regulated by sequential up-regulation of factors that include C/EBP (CCAAT/enhancer binding protein) -␤, -␦, and -␣ and peroxisome proliferator-activated receptor (PPAR) ␥ (reviewed in refs. 6 and 7) . Similarly, the basic helix-loop-helix (bHLH) transcription factors MyoD and Myogenin (Mgn) play essential roles for skeletal muscle lineage determination by directly regulating RNA pol II-mediated muscle-specific genes (8) (9) (10) . Withdrawal of proliferating progenitors and execution of differentiation programs coincide with a significant decrease in rRNA synthesis (11, 12) . One fundamental question is how RNA pol II-dependent phenotypic gene expression is coordinated with RNA pol I-mediated rRNA transcription during lineage commitment.
In this study, we demonstrate that during differentiation of mesenchymal progenitors into osteoblasts, myoblasts, or adipocytes, phenotypic regulatory factors critical for each lineage (e.g., Runx2, MyoD, Mgn, or C/EBP) suppress rRNA gene transcription and selectively interact with rRNA genes during interphase and mitosis. Our findings indicate that epigenetic regulation of rRNA synthesis by cell fate-determining factors is a broadly used mechanism for coordinating cell growth with lineage progression.
Results and Discussion
Cell Fate-Determining Factors Occupy rDNA Genes During Mesenchymal Cell Differentiation. Phenotypic commitment in pluripotent cells is controlled by reciprocal expression of transcription factors that are specific for different lineages. To assess the expression of rRNA genes in distinct mesenchymal lineages, proliferating C2C12 cells were differentiated into either myotubes or osteoblasts and morphological changes were monitored by light microscopy [supporting information (SI) Fig. S1 A and C]. rRNA genes were down-regulated during differentiation into either myotubes (Fig. 1A) or osteoblasts (Fig. 1C) . Each lineage exhibited induction of phenotypic transcription factors and differentiation markers, concomitant with down-regulation of genes for the other lineage. For example, sequential upregulation of the muscle regulatory factors MyoD and Mgn was observed in differentiated myoblasts, whereas the osteogenic factor Runx2 was down-regulated (Fig. 1B) . Several muscle differentiation markers were also induced (Fig. S1B) . Similarly, differentiated osteoblasts showed increased expression of Runx2 and osteoblast-related genes with a parallel decrease in MyoD as expected; Mgn, a late marker for muscle differentiation, is not present during osteoblast differentiation ( Fig. 1D and Fig. S1D ). We further investigated the expression of rRNA genes during mesenchymal cell differentiation into the adipocytic lineage. Consistent with our findings in muscle and bone differentiation, rRNA gene transcription and accumulation were reduced ( Fig.  1E ) with the expression of adipocyte markers (Fig. 1F) . Together, these observations indicate that the induction of phenotypic regulatory proteins in each lineage coincides with the down-regulation of rRNA genes.
Ribosomal DNA repeats contain functional Runx binding sites and E-boxes (the element recognized by bHLH proteins including Myc, MyoD, and Mgn) (13) (14) (15) . Bioinformatics analysis reveals that C/EBP motifs are also present in the rRNA genes ( Fig. 2A) . We therefore postulated that phenotypic transcription factors are linked to rRNA transcription during cell fate determination. ChIP analysis showed that MyoD and Mgn sequentially occupy rDNA promoter regions (Fig. 2B , primer sets A and B) during skeletal muscle differentiation. MyoD exhibited maximal rDNA occupancy on day 1 at the rDNA region amplified by primer set B, whereas binding of Mgn was increased at day 2 ( Fig. 2B ) at the regions covered by both primer sets A and B. We also observe significant occupancy of rDNA (primer set A) by MyoD at day 0, which is Fig. 1 . rRNA expression is down-regulated during mesenchymal cell differentiation. C2C12 cells were differentiated into either myoblast (A and B) or osteoblast (C and D) lineages, whereas 3T3-L1 cells were used for adipocyte differentiation (E and F). Cells were harvested at the indicated time points (i.e., days 0, 1, and 2). (A) Quantitative PCR analysis showed that both premature rRNA (E) and mature rRNA (F) levels were decreased during differentiation of all three lineages (A, C, and E). Western blot analysis confirmed the temporal expression of differentiation-related proteins specific for each lineage; MyoD and Mgn were up-regulated during skeletal muscle differentiation (B), Runx2 expression increased during osteogenesis (D), and C/EBP␣ and ␤ were induced during adipocyte differentiation (F). In contrast, expression of proliferation related proteins [e.g., Myc and cyclin A (CycA)] decreased as cells committed to various lineages, whereas levels of the rRNA transcriptional activator UBF remained unaltered. LaminB1 was used as a control for protein loading (B, D, and F). consistent with detectable expression of MyoD in the premyoblast C2C12 cells (Fig. 1B) . In contrast, increased rDNA occupancy by Runx2 was observed during osteogenic differentiation, with a parallel decrease in MyoD binding (Fig. 2C, primer sets A and B) . Similarly, we found that C/EBP␤ association with the rDNA regulatory regions increased during adipogenesis (Fig. 2D , primer sets A and C). Importantly, occupancy of rDNA by c-Myc, a known activator of rRNA transcription during proliferation (14, 15) , decreased during lineage commitment (Fig. S2) . Together, these findings indicate that phenotypic regulatory proteins have cell type-specific roles in down-regulation of rRNA gene transcription during lineage commitment.
Phenotypic Transcription Factors Interact with UBF-1 During Lineage
Progression. To address mechanisms of rRNA control by phenotypic factors, we examined protein interactions with RNA pol I regulatory components during myogenesis as representative of mesenchymal cell differentiation. We initially assessed whether MyoD and Mgn localize with UBF-1, a key regulator of ribosomal gene transcription that is present in nucleoli during interphase and resides on acrocentric chromosomes at nuclear organizing regions (NORs) during mitosis (16, 17) . Immunofluorescence (IF) microscopy revealed that an increasing subset (up to Ϸ55%) of UBF-1 foci colocalized with MyoD and Mgn at interphase nucleoli as myogenesis progressed (Fig. 3 A and B and Fig. S3 ). Consistent with our microscopy results, immunoprecipitation analysis showed that MyoD and UBF-1 interactions were increased during myotube formation (day 1) and sustained in multinucleated myotubes (day 2) (Fig. 3C) . Similarly, Mgn and UBF-1 interactions become prominent during myogenic differentiation (day 2) (Fig. 3D) . Analogous observations were made for Runx2 and UBF-1 during osteogenic induction of the same mesenchymal progenitors (data not shown). These findings further indicate that lineagedetermining factors directly participate in RNA pol I-mediated transcriptional control of rRNA genes during differentiation. Importantly, MyoD was also present and colocalized with UBF-1 at NORs on mitotic chromosomes (Fig. 4) . Hence, MyoD conveys intrinsic lineage specific regulatory cues through mitosis to progeny cells by an epigenetic mechanism.
Lineage Commitment Factors Suppress rRNA Transcription and Global
Protein Synthesis. We directly addressed the functional relevance of lineage-specific factors in RNA pol I-mediated transcriptional control. Quantitative PCR analysis revealed that forced expression of MyoD suppressed rRNA gene transcription (Ϸ2-to 2.5-fold), whereas mature 28 S rRNA levels remained essentially unchanged (Fig. 5A Left) . As expected, elevation of MyoD up-regulated muscle differentiation factors, including Mgn (Fig. 5A and Fig. S4A ). In vivo radio-labeling of newly translated proteins revealed that MyoD expression decreased global protein synthesis, concomitant with a decrease in pre-rRNA transcripts (Fig. 5A Right) . Consistent with MyoD-mediated suppression of rRNA genes, down-regulation of MyoD by RNA interference increased precursor rRNA levels and global protein synthesis (Fig. 5B) , coincident with decrease levels of muscle differentiation markers (Fig. S4B) . These findings establish MyoD as a lineage-specific transcriptional suppressor of rRNA genes in myoblasts.
Because MyoD induces Mgn (Fig. 5A) , which also binds E-boxes, we addressed whether Mgn also regulates rRNA genes. Using RNA interference against Mgn, we found that MyoD-mediated suppression of rRNA genes was maintained in the absence of Mgn (Fig. 5C and Fig. S4C ). Forced expression of Mgn down-regulated rRNA expression and global protein synthesis (Fig. 5D and Fig. S4D ). Thus, MyoD and Mgn can each independently suppress rRNA gene expression. Temporal expression of MyoD and Mgn (Fig. 1B) and sequential rDNA occupancy by both factors (Fig. 2B) , together with these findings, suggest that MyoD and Mgn down-regulate rRNA gene transcription at different stages of skeletal muscle differentiation. Similarly, we observed down-regulation of RNA pol I-mediated control of rRNA gene expression when either the osteoblast-related factor Runx2 (Fig. 6A) or the adipocyte regulator C/EBP␤ (Fig. 6B) were expressed. Taken together, our findings indicate that rRNA gene suppression is a shared property of phenotype-determining regulatory proteins.
In conclusion, this study establishes a common developmental event through which phenotypic regulatory factors coordinately control cell growth and lineage commitment. We find that suppression of ribosomal gene transcription and global protein synthesis during cell fate determination is mediated by interactions of lineage commitment factors with rRNA genes and cognate transcriptional regulators. It has been previously established that the cancer-related cell growth regulatory protein cMyc activates rRNA genes in proliferating cells (14, 15) . During mesenchymal cell differentiation, we now show decreased occupancy of rDNA repeats by cMyc, concomitant with replacement by myogenic (MyoD and Mgn), osteogenic (Runx2), or adipogenic (C/EBP) regulatory factors that suppress ribogenesis. Therefore, we postulate that rRNA gene transcription is developmentally controlled by distinct mechanisms involving common cell growth regulatory activators and lineage-specific transcriptional suppressors. The adipogenic factor C/EBP␤ has been shown to localize to mitotic chromosomes during the proliferative stage of 3T3-L1 adipocytes (18) . In addition, we find that cell fate-determining factors including MyoD and Runx2 (13) associate with NORs during mitosis and transition into interphase nucleoli in progeny cells. Together, these findings provide a unique epigenetic mechanism for the establishment of phenotype-specific rRNA gene regulation and its maintenance during successive mitotic divisions of committed cells.
Materials and Methods
Cell Culture and Differentiation. Mouse myoblast C2C12 cells were grown in DMEM containing 10% FBS growth medium. To differentiate the cells into myotubes, 90% confluent population of cells was switched to differentiation medium containing 2% horse serum. Cells were harvested at the time of switching cells from growth to differentiation medium (day 0) and after 24 h (day 1) and 48 h (day 2). For transdifferentiation of C2C12 cells into osteogenic lineage (4), cells were treated with BMP-2 (kindly provided by John Wozney, Wyeth Research, Cambridge, MA; 200 ng/ml) in DMEM containing 2% FBS. Cells were harvested at the time of BMP-2 treatment (day 0) and 24 h (day 1) and 48 h (day 2) after treatment. Differentiation of 3T3-L1 cells into adipocyte lineage has been described (19) .
Plasmid Constructs. MyoD and Mgn were expressed by using retroviruses containing cDNA for the respective gene. Both retroviruses have been reported (10, 20, 21) . Retroviruses were produced by transfecting Bosc23 for 48 h, and C2C12 cells were infected with the medium containing the retroviruses. Mgn knockdown was obtained by shRNA-mediated silencing of the gene. The vector backbone and Mgn shRNA constructs have been published (22) . C/EBP␤ and Runx2 viruses used have been reported (19, 23) .
In Situ IF Microscopy. C2C12 cells, grown on gelatin-coated coverslips, were processed for in situ IF as described (13) . In brief, cells were rinsed twice with ice-cold PBS and fixed in 3.7% formaldehyde in PBS for 10 min on ice. After rinsing once with PBS, cells were permeabilized in 0.1% Triton X-100 in PBS, and rinsed twice with PBSA (0.5% BSA in PBS) followed by 1-h incubation with primary antibody at 37°C. Rabbit polyclonal antibodies against MyoD (1:500; C-20) and Mgn (1:500; M-225) were used, and mouse monoclonal antibody was raised against UBF-1 (1:500; F-9). All antibodies were purchased from Santa Cruz Biotechnology. The secondary antibodies used were either antimouse Alexa 594 or anti-rabbit Alexa 488 (1:800; Molecular Probes). DNA was visualized by DAPI staining. Immunostaining of cell preparations was recorded with an epifluorescence Zeiss Axioplan 2 microscope equipped with a charged coupled device. Images were captured and analyzed by MetaMorph Imaging Software (Universal Imaging).
Coimmunoprecipitation and Western Blot Analysis. Proliferating and differentiated C2C12 samples were washed with ice-cold PBS and harvested in sonication buffer [50 mM NaCl, 50 mM Tris (pH 8.0), 1% NP-40, 25 mM MG132, and 1ϫ protease inhibitor mixture (Roche)]. Lysates were incubated overnight at 4°C with 3 g of rabbit antibodies against MyoD (C- 20) or Mgn (M-225). Lysates were then incubated with protein A/G beads for 2 h, followed by four washes with wash buffer [50 mM NaCl, 20 mM Tris (pH 8.3), 0.5% Na-deoxycholate, 0.5% Nonidet P-40, 2 mM EDTA, 25 mM MG132, and 1ϫ protease inhibitor mixture]. The total cell lysates and immunoprecipitated protein complexes were resolved by 8% SDS/PAGE and transferred to polyvinylidene difluoride membranes (Immobilon-P; Millipore). Blots were incubated with different antibodies as follows: mouse MyoD mAb from BD PharMingen (1:1,000); Mgn (F5D; 1:500); rabbit polyclonal antibodies from Santa Cruz Biotechnology for MyoD (C-20; 1:1,000), C/EBP␤ (C-19; 1:1,000), C/EBP␣ (14AA; 1:1,000), UBF-1 (F-9; 1:1,000), CyclinA (H-432; 1:1,000), c-Myc (N-262; 1:500), Cdk2 (M2; 1:1,000), Runx2 (M-70; 1:1,000), and LaminB1 (1:5,000; Zymed). Membranes were then incubated with HRP-conjugated secondary antibodies against rabbit or mouse (1:2,000). Proteins bands were visualized with a chemiluminescence detection kit (Perkin-Elmer Life Sciences).
